• Comment

Experimental Drug Might Beat Aspirin in Preventing Repeat Strokes: Study

It's not yet FDA-approved, but apixaban cut clot risk caused by abnormal heartbeat

February 1, 2012 RSS Feed Print

More information

For more on atrial fibrillation, visit the U.S. National Heart, Lung, and Blood Institute.

Copyright © 2012 HealthDay. All rights reserved.

Tags:
research,
over the counter drugs,
stroke,
blood disorders,
therapy,
prescription drugs,
heart disease

Reader Comments

Add Your Thoughts
Your comment will be posted immediately, unless it is spam or contains profanity. For more information, please see our Comments FAQ.

Eat + Run

advertisement

advertisement